Gene · 7307
Papers3,382
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,181 to 1,200 of 3,382
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Interrogating cell type-specific cooperation of transcriptional regulators in 3D chromatin. | iScience | 2021 | 34888502 | PubTator, text mining | PubMed |
| Integrated Clinical Genotype-Phenotype Characteristics of Blastic Plasmacytoid Dendritic Cell Neoplasm. | Cancers (Basel) | 2021 | 34884997 | PubTator, text mining | PubMed |
| Integrated analysis of the functions and prognostic values of RNA-binding proteins in neuroblastoma. | PLoS One | 2021 | 34879089 | PubTator, text mining | PubMed |
| Myelodysplastic Syndromes and Modalities of Treatment: An Updated Literature Review. | Cureus | 2021 | 34873563 | PubTator, text mining | PubMed |
| Hybrid or Mixed Myelodysplastic/Myeloproliferative Disorders - Epidemiological Features and Overview. | Front Oncol | 2021 | 34869027 | PubTator, text mining | PubMed |
| Lin28A/CENPE Promoting the Proliferation and Chemoresistance of Acute Myeloid Leukemia. | Front Oncol | 2021 | 34868981 | PubTator, text mining | PubMed |
| Atypical Chronic Myelogenous Leukemia, BCR-ABL1 Negative: Diagnostic Criteria and Treatment Approaches. | Front Oncol | 2021 | 34868917 | PubTator, text mining | PubMed |
| Case Report: Evolution of a Severe Vascular Refractory Form of ECD Requiring Liver Transplantation Correlated With the Change in the Monocyte Subset Analysis. | Front Immunol | 2021 | 34867991 | PubTator, text mining | PubMed |
| Immune Dysregulation and Infectious Complications in MPN Patients Treated With JAK Inhibitors. | Front Immunol | 2021 | 34867980 | PubTator, text mining | PubMed |
| Targeting Zinc Finger Proteins with Exogenous Metals and Molecules: Lessons learned from Tristetraprolin, a CCCH type Zinc Finger. | Eur J Inorg Chem | 2021 | 34867080 | PubTator, text mining | PubMed |
| Evaluation of the Mutation Profile via Next-Generation Sequencing in a Turkish Population With Non-small Cell Lung Cancer. | Balkan Med J | 2021 | 34860166 | PubTator, text mining | PubMed |
| Molecular Pathogenesis of BCR-ABL-Negative Atypical Chronic Myeloid Leukemia. | Front Oncol | 2021 | 34858828 | PubTator, text mining | PubMed |
| Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug. | J Exp Clin Cancer Res | 2021 | 34857016 | PubTator, text mining | PubMed |
| Deciphering the nonsense-mediated mRNA decay pathway to identify cancer cell vulnerabilities for effective cancer therapy. | J Exp Clin Cancer Res | 2021 | 34852841 | PubTator, text mining | PubMed |
| RBPSpot: Learning on appropriate contextual information for RBP binding sites discovery. | iScience | 2021 | 34841226 | PubTator, text mining | PubMed |
| Management of Invasive Infections due to a Rare Arthroconidial Yeast, Saprochaete capitata, in Two Patients with Acute Hematological Malignancies. | Vaccines (Basel) | 2021 | 34835220 | PubTator, text mining | PubMed |
| New Horizons in Myeloproliferative Neoplasms Treatment: A Review of Current and Future Therapeutic Options. | Medicina (Kaunas) | 2021 | 34833399 | PubTator, text mining | PubMed |
| Precision Medicine in Systemic Mastocytosis. | Medicina (Kaunas) | 2021 | 34833353 | PubTator, text mining | PubMed |
| Genetic Landscape of Myeloproliferative Neoplasms with an Emphasis on Molecular Diagnostic Laboratory Testing. | Life (Basel) | 2021 | 34833034 | PubTator, text mining | PubMed |
| Gene Expression Profiling of Mycosis Fungoides in Early and Tumor Stage-A Proof-of-Concept Study Using Laser Capture/Single Cell Microdissection and NanoString Analysis. | Cells | 2021 | 34831413 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7307/papers?page=60